Moody’s Downgrades Banks, Pharma Stocks Surge, UPS Cuts Forecast 8/8/23
Squawk on the Street
00:00
The Stock's Underperformers
Jim Boulden: I don't think it's going to go up. The numbers we see, David, on China, reflect just a huge botching of the economy by lifetime president Xi. He says Paramount reported, and it was okay. But as you might expect, talking about, hey, listen, we're seeing top line growth. We've seen 40% growth at direct to consumer. They're working their way towards break even. It goes towards that reduction in leverage which is obviously important for these companies.
Play episode from 27:10
Transcript
